Hook & thesis
Upstart (UPST) has been hammered since late 2025 after a model reset and a disclosure that reduced borrower approvals. The market has pushed the stock to $25.93 intraday on 04/01/2026, only slightly above its recent low of $23.965. That sell-off looks overdone: the business is generating positive earnings per share, posted strong revenue growth last year, and operates an AI-first lending engine that should regain approval mix and conversion as the model adjustments settle.
My trade: buy the pullback and position for a mid-term recovery driven by re-rating and short-covering. Entry $25.95, target $40.00, stop loss $23.50. The plan is sized for mid-term upside over the next 45 trading days with clear risk limits.
What the company does and why the market should care
Upstart operates a cloud-based AI lending platform across Personal Lending, Auto Lending, and Other (HELOCs and related). Its core product is underwriting powered by machine learning that aims to price credit more accurately and expand access while lowering costs for lenders. That combination matters in a credit cycle: higher risk-adjusted approval and better loss forecasting translate directly into revenue and margin expansion for a platform provider.
The market cares because Upstart is not just a technology vendor; it owns origination economics through loan placement and increasingly via plans to expand deposit-taking and direct lending if its charter ambitions proceed. At a market cap near $2.54B and EPS roughly $0.57, Upstart sits at the intersection of AI multiple expansion and cyclically depressed fintech sentiment.
Hard numbers that back the bull case
| Metric | Value |
|---|---|
| Current price (intraday) | $25.93 |
| Market cap | $2,541,650,834.70 |
| EPS (trailing) | $0.57 |
| P/E | ~45.4 |
| Price / Book | ~3.05 |
| Price / Sales | ~2.69 |
| Enterprise value | $3,656,662,738 |
| Free cash flow (most recent) | -$166,132,000 |
Two points stand out. First, Upstart reported a meaningful top-line surge in 2025 (one report cited a 64% revenue increase year-over-year), which suggests the core product still scales when loan demand and approval mix cooperate. Second, the company is profitable on an EPS basis and trades at reasonable multiples for a growth fintech: P/S ~2.7 and P/E in the mid-40s while the business is still growing fast. That combination—profitability plus growth—explains why a valuation rebound is plausible once noise around the model and legal inquiries abates.
Technical read and investor context
Technicals are supportive for a bounce. The stock sits near its 10-day simple moving average ($25.93) and below the 20- and 50-day averages ($26.64 and $31.91 respectively), giving a defined risk profile for buyers. RSI at ~42 signals the shares are not yet oversold to extremes. MACD shows bullish momentum with a positive histogram despite negative MACD line levels - a sign the downtrend has lost steam. Short interest is meaningful: recent settlement on 03/13/2026 showed ~27.8M shares short, and short-volume metrics across March show elevated short activity that could fuel short-covering rallies.
Valuation framing
At a market cap near $2.54B and enterprise value about $3.66B, Upstart is priced like a challenged mid-cap fintech, not a high-growth AI darling. P/S of ~2.7 and P/B ~3.05 leave room for a valuation rerating if growth normalizes and the market regains confidence. Compare that to fintech peers that trade at richer multiples when growth and earnings visibility improve. Given the company already posts positive EPS, much of the upside rests on sentiment and execution recovery rather than a long wait for profitability.
Catalysts (what could move the stock higher)
- Operational stabilization: if borrower approval rates and conversion recover as Model 22 tweaks settle, reported originations and revenue could accelerate again.
- Short-covering: with >25M shares short and elevated short-volume in March, a technical squeeze is a plausible near-term catalyst if price moves above $28-$30.
- Regulatory/charter progress: renewed clarity on the national bank charter application or partnerships enabling deposit-taking would materially expand margins and the company’s addressable revenue base.
- Positive quarterly results or guidance that beat lowered expectations - the market tends to reward surprises for stocks that are already beaten down.
Trade plan (actionable)
- Trade direction: Long UPST.
- Entry: $25.95 (limit buy).
- Target: $40.00 — my primary target over the mid-term as sentiment recovers and multiple expansion returns.
- Stop loss: $23.50 — a hard stop just below the recent $23.965 low to protect capital if the sell-off broadens.
- Horizon: mid term (45 trading days). I expect this trade to play out within ~9 weeks because the main drivers are sentiment normalization and technical squeeze potential; both manifest faster than multi-quarter fundamental turns.
Size & risk management
This is a volatile, news-driven name. Keep position sizing small within a diversified portfolio and use the stop strictly. If you prefer more defensive exposure, layer in a smaller initial position and add on a confirmed bounce above $28 with volume.
Risks and counterarguments
- Model risk and execution drag. The root cause of the recent sell-off was a model change that reduced approvals and conversion. If subsequent model versions continue to underperform, revenue and originations could stay depressed and margins compress further.
- Regulatory and legal overhang. The Portnoy Law Firm launched an investigation after the November disclosure (03/23/2026 press coverage). Litigation or enforcement outcomes could be costly and weigh on the multiple.
- Funding and capital risks. Upstart’s enterprise value and debt-to-equity (~2.35) indicate leverage. If credit markets tighten and originations fall, cash flow could remain negative—free cash flow was -$166.1M most recently—which would limit any re-rating.
- Market multiple compression. The broader fintech/comps trade can compress quickly. Analysts have warned the stock could fall materially under stressed outcomes; further multiple compression from macro shocks would hurt an equity that already trades with cyclical risk.
- Short-term volatility and headline risk. Elevated short interest and large daily short volumes in March mean the stock can spike or plunge on headlines; losses can be swift if stops are not honored.
Counterargument: The bear case is credible: if the model problems prove structural and originations don't recover, Upstart may revert to lower growth and weaker margins, justifying the low price. That said, the company already delivers positive EPS and showed strong top-line growth in 2025, so the turnaround scenario is realistic and faster than a full operational rebuild.
What would change my mind
I will revisit the bullish stance if any of the following occur: a) the company reports another quarter with materially lower approvals and deteriorating credit economics; b) a damaging regulatory ruling or litigation outcome that results in sizeable reserves or penalties; c) evidence that originator or partner appetite for Upstart-originated paper meaningfully drops. Conversely, material progress on the national bank charter, a clear operational stabilization, or a strong beat-and-raise quarter would strengthen the bull case and justify larger position sizing.
Conclusion
Upstart’s plunge has left a mispriced opportunity for disciplined buyers: positive earnings, meaningful revenue growth in 2025, and an AI-driven product that still has runway. Trade this as a mid-term tactical long with strict risk controls: entry $25.95, target $40.00, stop $23.50, horizon ~45 trading days. The trade is not without real risks—model execution and regulatory noise top the list—but the upside versus downside is attractive for a measured position given the company’s current fundamentals and technical setup.
Trade plan recap: Buy $25.95; target $40.00 in ~45 trading days; stop $23.50. Keep position size conservative given the headline and model risk.